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Abstract 
ABSTRACT 
Review on i(X)(q10) in female patients. 
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Identity 
Figure 1.  Partial karyotypes (G-banding) with i(X)(q10) 
Clinics and pathology 
Disease 
i(X)(q10) occurs in a variety of hematologic 
malignancies, in both myeloid and lymphoid 
disorders, including ALL, NHL, AML, MDS and 
CML.  
 Chronic myeloid leukemia (CML): 2 patients 
(Lyall and Garson, 1978; Karrman et al., 2007). 
 Myelodysplastic syndrome (MDS) was diagnosed 
in 2 patients (Wilkens et al, 1998; Kearns et al., 
2004). 
 Acute myeloid leukemia (AML): there were 8 
patients with AML-M2, six of them had 
translocation t(8;21)(q22;q22) (Shiraishi et al, 1982; 
Minamihisamatsu et al, 1988; Tien et al, 1988; 
Kwong et al, 1993; Ma et al, 1997; Paskulin et al, 
1998). 
 Acute lymphoblastic leukemia (ALL): was 
diagnosed in 6 patients. Three of them with relapse 
of ALL after chemotherapy (CT) (Arthur et al., 
1982; Gindina T, own cases, table 1,#18, #19), two 
patients had unbalanced translocation 
t(1;19)(q23;p13) (Pui et al, 1990; Gindina T, table 1, 
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#18), one patient had translocation t(4;11)(q21;q23) 
(Arthur et al, 1982).  
 Follicular lymphoma (FL): 3 patients (Horsman et 
al, 2001; Fan and Rizkalla 2003).  
 Burkitt lymphoma (BL) was diagnosed in 2 
patients (Goyns et al., 1993; Trcic et al., 2010).  
 Diffuse large B-cell lymphoma  (DLBCL): 2 
patients (Bloomfield et al., 1983; Dave et al, 2002).  
 Mature B-cell neoplasm : 2 patients (Ueda et al, 
1997; Adeyinka et al, 2007). 
Epidemiology 
I(X)(q10) has been observed in female patients with 
a median age of 27 years (range, 0,9 to 54 years).  
 





Disease Karyotype Author 
1 40, F CML 46,X,i(X)(q10),del(1),t(9;22),t(17;17)(q12;q25) 
Karrman et 
al, 2007 
2 ?, F CML 46,X,i(X)(q10),t(9;22)/47,idem,+der(22)t(9;22) 
Lyall&Garson, 
1978 
3 ?, F MDS 47,X,i(X)(q10),+21 
Kearns et al, 
2004 
4 ?, F MDS 47,XX,+i(X)(q10) 
Wilkens et al, 
1998 
5 54, F AML (M2) 45,X,-X,del(9)(q12q22)[6]/46,X,i(X)(q10)[6] 
Han et al, 
2002 
6 ?, F AML (M2) 46,X,i(X)(q10),t(8;21)(q22;q22) 
Kwong et al, 
1993 
7 33, F AML (M2) 46,X,i(X)(q10),t(8;21)(q22;q22)[5]/46,XX[3] 
Ma et al, 
1997 
8 ?, F AML (M2) 47,X,i(X)(q10),+8,t(8;21)(q22;q22) 
Minamihisam
atsu et al, 
1988 
9 45, F AML (M2) 
88,XXYY,+i(X)(q10)x2,i(1)(q10),dup(2)(q11q21)x2,del(3)(q21),del(5)(q13q35)x2,-6,-6,-9,-9,-12,i(12)(q10),-
15,-15,-17,-17,-21,add(21)(q22),add(22)(q12)x2,+4mar 
Pang et al, 
2015 
10 30, F AML (M2) 46,X,i(X)(q10),t(8;21)(q22;q22)/46,idem,del(9)(q13q22) 
Tien et al, 
1988 
11 ?, F AML (M2) 46,XX,t(8;21)(q22;q22)/46,idem,i(X)(q10)[7]/45,idem,-X[5] 
Paskulin et al, 
1998 
12 40, F AML, (M2) 46,X,i(X)(q10),t(8;21)(q22;q22) 
Shiraishi et al, 
1982 
13 10, F AML, NOS 46,X,i(X)(q10) 
Debiec-
Rychter et al, 
1985 
14 ?, F ALL 47,X,i(X)(q10),t(10;11)(p13;q13),+19 
Heerema et 
al, 1998 
15 0,9, F ALL 44,X,i(X)(q10),-7,-8,der(10)t(8;10)(q11;p13),der(19)t(1;19)(q23;p13) 
Pui et al, 
1990 
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16 4,5, F ALL 47,X,i(X)(q10),+21 
Pui et al, 
1992 
17 31, F 
Relapse of 
ALL after CT 
46,X,i(X)(q10),t(4;11)(q21;q23) 
Arthur et al, 
1982 
18 12, F 
Relapse of 




19 22, F 
Relapse of 





20 ?, F FL 69-72,X,i(X)(q10)x2,+X,+1,-3,add(10)(q26),+11,-14,t(14;18)(q32;q21),+21,+22 
Fan and 
Rizkalla, 2003 





22 ?, F FL 46,X,i(X)(q10),t(11;21)(q23;q22),t(14;18)(q32;q21) 
Horsman et 
al, 2001 
23 ?, F BL 49,X,i(X)(q10),+2,+3,+del(6)(q?15),t(9;13)(p13;q32),der(10)t(X;10)(q13;p13),der(14)t(1;14)(q25;q32) 
Goyns et al, 
1993 
24 ?, F BL 46,XX,dup(1)(q21q31),i(7)(q10),t(8;14)(q24;q32)/46,idem,i(X)(q10) 
Trcic et al, 
2010 
25 8, F DLBCL 49,X,i(X)(q10),+2,t(3;22)(q21;q11),del(6)(p21),+7,t(8;14)(q24;q32),+10 
Bloomfield et 
al, 1983 
26 ?, F DLBCL 48,XX,+i(X)(q10),+5,dup(6)(p21p25),i(7)(q10),der(10)t(6;10)(p21;p15)[19]/46,XX[1] 
Dave et al, 
2002 















Ueda at al, 
1997 
CML: Chronic myeloid leukemia; MDS: 
Myelodysplastic syndrome; AML: Acute myeloid 
leukemia; ALL: Acute lymphoblastic leukemia; FL: 
Follicular lymphoma; BL: Burkitt lymphoma; 
DLBCL: Diffuse large B-cell lymphoma; CT: 
chemotherapy; NOS not otherwise specified. 
Cytogenetics 
Additional anomalies 
As a single anomaly, isochromosome Xq was 
described only in two cases of myeloid malignancies 
(Debiek-Rychter et al, 1985; Wilkens et al, 1998). 
Double extra i(X)(q10) was present in 5 patients 
(Ueda et al, 1997; Wilkens et al, 1998; Horsman et 
al, 2001; Dave et al, 2002; Pang et al, 2015). 
Additional chromosome abnormalities were 
observed in 26/28 patients. i(X)(q10) has been 
demonstrated in six cases with RUNX1 / RUNX1T1 
AML (Shiraishi et al, 1982; Minamihisamatsu et al, 
1988; Tien et al, 1988; Kwong et al, 1993; Ma et al, 
1997; Paskulin et al, 1998) , two  cases with TCF3 / 
PBX1 ALL (Pui et al, 1990; Gindina T, table 1, #18) 
and one case with KMT2A / AFF1 (Arthur et al, 
1982). Associated in combination with other 
isochromosomes in 4 patients (Dave et al, 2002; 
Adeyinka et al, 2007; Trcic et al, 2010; Pang et al, 
2015), del(9q) in 3 patients (Tien et al, 1988; Han et 
al, 2002; Gindina T, table 1, #19) and extra 
chromosome 21 in 2 (Kearns et al., 2004; Pui et al., 
1992). In lymphomas, i(X)(q10) is usually part of a 
complex karyotype. 
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As a result of the formation of  the isochromosome, 
there is the loss of a normal  X chromosome, and the 
structural abnormality leads to monosomy for Xp 
and trisomy for Xq. It is not known whether the 
overexpression of a proto-oncogene (or other gene) 
or the deletion of a tumor-suppressor gene from the 
isochromosome contributes to development or 
proliferation of tumor cells in these cases. 
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